Your browser doesn't support javascript.
loading
Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes.
Tavares, G; Marques, D; Barra, C; Rosendo-Silva, D; Costa, A; Rodrigues, T; Gasparini, P; Melo, B F; Sacramento, J F; Seiça, R; Conde, S V; Matafome, P.
Affiliation
  • Tavares G; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Portugal; Clinical-Academic Center of Coimbra, Coimbra, Portugal; CEDOC, NOVA Med
  • Marques D; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal.
  • Barra C; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Portugal; Clinical-Academic Center of Coimbra, Coimbra, Portugal.
  • Rosendo-Silva D; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Portugal; Clinical-Academic Center of Coimbra, Coimbra, Portugal.
  • Costa A; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal.
  • Rodrigues T; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal.
  • Gasparini P; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal.
  • Melo BF; CEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal.
  • Sacramento JF; CEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal.
  • Seiça R; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal; Clinical-Academic Center of Coimbra, Coimbra, Portugal.
  • Conde SV; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Portugal.
  • Matafome P; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Portugal; Clinical-Academic Center of Coimbra, Coimbra, Portugal; Instituto Polit
Mol Metab ; 51: 101241, 2021 09.
Article in En | MEDLINE | ID: mdl-33933677
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bromocriptine / Dopamine Agonists / Diabetes Mellitus, Type 2 / Intra-Abdominal Fat / Obesity Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Animals / Female / Humans / Male / Middle aged Language: En Journal: Mol Metab Year: 2021 Document type: Article Country of publication: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bromocriptine / Dopamine Agonists / Diabetes Mellitus, Type 2 / Intra-Abdominal Fat / Obesity Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Animals / Female / Humans / Male / Middle aged Language: En Journal: Mol Metab Year: 2021 Document type: Article Country of publication: Alemania